No Data
No Data
No Data
No Data
No Data
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Stockhouse Mar 13 17:15 ET
Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the r
AccesswireFeb 26 19:38 ET
Intellipharmaceutics International Inc. Announces Stock Option Grant
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the re
AccesswireFeb 8 16:35 ET
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
Stockhouse Jan 2 17:40 ET
Intellipharmaceutics International GAAP EPS of -$0.06
Seeking AlphaOct 16, 2023 17:30 ET
Intellipharmaceutics International GAAP EPS of $0.00, Revenue of $480.21M
Seeking AlphaJul 17, 2023 10:55 ET
No Data
No Data
72824481 : for myself I will never touch this one !!! the vol is tooooo low
Charles YarbroughOP : how do you decide which ones to buy and the right time to get in?